Context Therapeutics shareholders ratify CohnReznick as auditor for FY 2022

Context Therapeutics Inc.

Annual meeting held June 2, 2022; quorum of 9,161,941 shares (57.38%) present.
Proposal 1: Ratification of CohnReznick LLP as independent auditor for 2022.
Votes: 9,144,524 For, 8,877 Against, 8,540 Abstentions; no broker non-votes.
Auditor appointment for year ending December 31, 2022 approved.

item 5.07

Context Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001842952-22-000050

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.